EP3210965

GRÜNENTHAL GMBH
Application Number
EP17161440A
Filing Date
Jul 23, 2007
Status
Granted And Under Opposition
Oct 18, 2021
Grant Date
Nov 17, 2021
External Links
Slate, Register

Biblio Summary

The patent EP3210965B1 was granted on Nov 17, 2021 by Grünenthal Gmbh The patent is currently Granted And Under Opposition.

The table below shows 3 patent oppositions filed on the patent at EPO, listing each opposing company and filing date. Tracking these filings indicates that the applicant is active in this industry, while opposing companies may be signaling their own interest in competing within the same space. These disputes are essential for insights into competitor actions, patent strategy and emerging technological trends.

CompanyOpposition DateOpposition Status

Get instant alerts for new oppositions and patent status changes

INSTONE, TERRY/READ, HOWARD GRAHAM/APPLEYARD LEES IP LLPAug 17, 2022ADMISSIBLE
ELKINGTON AND FIFE LLPAug 16, 2022ADMISSIBLE
SCORPIO IP LIMITEDAug 16, 2022WITHDRAWN

The table below shows the patents of Grünenthal Gmbh that have been opposed by other companies.

Patent NumberTitleGrant DateOpposition Count
EP3995135Prolonged Release Dosage Form Of Tapentadol L-(+)- Tartaric Acid SaltJul 13, 20222
EP3656765Salts Or Co-Crystals Of 3-(3-Dimethylamino-1-Ethyl-2-Methyl-Propyl)-PhenolApr 14, 20216
EP3241550(1R, 2R)-3-(Dimenthyl Amino-1-Ethyl-2-Methyl-Propyl) Phenol For Treating Painful InflammationsJul 22, 20204